Latest SEC Filings

Accel Entertainment, Inc.Accel Entertainment Reports $351.6 Million Revenue for Q1 2026, Driven by Gaming Growth

American Well CorpAmerican Well Corporation Reports Q1 2026 Financial Results with 18% Revenue Decline

Live Nation Entertainment, Inc.Live Nation Reports 12% Revenue Growth to $3.79 Billion in Q1 2026

Intapp, Inc.Intapp Reports 13% Revenue Growth to $146M, Net Loss of $15.5M for Quarter Ended March 31, 2026

TransMedics Group, Inc.TransMedics Reports 21.2% Revenue Growth to $173.9 Million in Q1 2026

UL Solutions Inc.UL Solutions Inc. Reports 7.5% Revenue Growth to $758 Million in Q1 2026

JBG SMITH PropertiesJBG SMITH Properties Reports $23M Net Loss in Q1 2026, Revenue Increases to $127.6M

Community Healthcare Trust IncCommunity Healthcare Trust Reports Q1 2026 Financial Results with $2.5 Million Net Income

Hercules Capital, Inc.Hercules Capital Reports Q1 2026 Financial Results with Increased Investment Income

Angi Inc.Angi Inc. Reports 3% Revenue Decline and Net Loss in Q1 2026

Editas Medicine, Inc.Editas Medicine Reports $24.98 Million Net Loss in Q1 2026, Focuses on Gene Editing Candidate

GENERAC HOLDINGS INC.Generac Holdings Inc. Reports 12.4% Revenue Growth to $1.06 Billion in Q1 2026

Angel Oak Mortgage REIT, Inc.Angel Oak Mortgage REIT Reports $7.4 Million Net Loss in Q1 2026

COMPX INTERNATIONAL INCCompX International Reports Modest Increase in Net Sales and Profitability for Q1 2026

Dave Inc./DEDave Inc. Reports 47% Revenue Growth to $158.4 Million in Latest Quarter

RHYTHM PHARMACEUTICALS, INC.Rhythm Pharmaceuticals Reports 84% Revenue Growth to $60.1 Million in Q1 2026

Relay Therapeutics, Inc.Relay Therapeutics Reports $3 Million Revenue and $73.3 Million Net Loss in Q1 2026

Aptiv PLCAptiv Reports 5% Net Sales Increase to $5.1 Billion in Q1 2026

SUPERNUS PHARMACEUTICALS, INC.Supernus Pharmaceuticals Reports 39% Revenue Growth to $207.7 Million in Q1 2026

MORGAN STANLEYMorgan Stanley Reports 16% Revenue Growth to $20.6 Billion in Q1 2026

CPS TECHNOLOGIES CORP/DE/CPS Technologies Reports 6% Revenue Decline and Net Loss in First Quarter of 2026

IDEXX LABORATORIES INC /DEIDEXX Laboratories Reports 14.3% Revenue Growth to $1.14 Billion in Q1 2026

Klaviyo, Inc.Klaviyo Reports 27.9% Revenue Growth to $358M in Q1 2026

BrightView Holdings, Inc.BrightView Holdings Reports Q2 Fiscal 2026 Revenue Growth but Increased Net Loss

MERCURY GENERAL CORPMercury General Corporation Reports 10.5% Revenue Growth and Net Income Turnaround in Q1 2026